Ian Flinn, MD, PhD, attended the Johns Hopkins University School of Medicine, Baltimore, MD, before completing residency training at the University of Michigan Medical Center, Ann Arbor, MI, and a Hematology and Medical Oncology fellowship at Johns Hopkins. He currently practices as a Hematologist/Oncologist at the Tennessee Oncology Center for Blood Cancers, Nashville, TN, and is Director of Lymphoma Research at the Sarah Cannon Research Institute, Nashville, TN. Dr Flinn is a member of the CLL Research Consortium, the American Society of Clinical Oncology and the American Society of Hematology.